These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 24652411)

  • 21. Adolescents with HIV and transition to adult care in the Caribbean, Central America and South America, Eastern Europe and Asia and Pacific regions.
    Bailey H; Cruz MLS; Songtaweesin WN; Puthanakit T
    J Int AIDS Soc; 2017 May; 20(Suppl 3):21475. PubMed ID: 28530040
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Optimising HIV spending in 12 eastern European and central Asian countries: a modelling study.
    Ten Brink DC; Bowring AL; Martin-Hughes R; Wulan N; Xiao Y; Burke K; Tidhar T; Walsh T; Kelly SL; Shattock A; Palmer T; Maxim C; Zhang S; Scott N
    Lancet HIV; 2024 Oct; 11(10):e690-e699. PubMed ID: 39245062
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Global oral inequalities in HIV infection.
    Challacombe SJ
    Oral Dis; 2016 Apr; 22 Suppl 1():35-41. PubMed ID: 27109270
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The HIV epidemic in Southern Africa - Is an AIDS-free generation possible?
    Delva W; Abdool Karim Q
    Curr HIV/AIDS Rep; 2014 Jun; 11(2):99-108. PubMed ID: 24676559
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Drug use, HIV, HCV and TB: major interlinked challenges in Eastern Europe and Central Asia.
    Kazatchkine M
    J Int AIDS Soc; 2014; 17(4 Suppl 3):19501. PubMed ID: 25394010
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Access and coverage of needle and syringe programmes (NSP) in Central and Eastern Europe and Central Asia.
    Aceijas C; Hickman M; Donoghoe MC; Burrows D; Stuikyte R
    Addiction; 2007 Aug; 102(8):1244-50. PubMed ID: 17565564
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Access to highly active antiretroviral therapy for injection drug users: adherence, resistance, and death.
    Vlahov D; Celentano DD
    Cad Saude Publica; 2006 Apr; 22(4):705-18. PubMed ID: 16612417
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Implementation of harm reduction in Central and Eastern Europe and Central Asia.
    Sarang A; Stuikyte R; Bykov R
    Int J Drug Policy; 2007 Mar; 18(2):129-35. PubMed ID: 17689355
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The scale-up of antiretroviral therapy coverage was strongly associated with the declining tuberculosis morbidity in Africa during 2000-2018.
    Boah M; Jin B; Adampah T; Wang W; Wang K
    Public Health; 2021 Feb; 191():48-54. PubMed ID: 33508661
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Late for the epidemic: HIV/AIDS in Eastern Europe.
    Cohen J
    Science; 2010 Jul; 329(5988):160, 162-4. PubMed ID: 20616262
    [No Abstract]   [Full Text] [Related]  

  • 31. HIV in Europe.
    Põder A; Haldre M
    Clin Dermatol; 2014; 32(2):282-5. PubMed ID: 24559564
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hepatitis B, hepatitis C and HIV prevalence and related sexual and substance use risk practices among key populations who access HIV prevention, treatment and related services in South Africa: findings from a seven-city cross-sectional survey (2017).
    Scheibe A; Young K; Versfeld A; Spearman CW; Sonderup MW; Prabdial-Sing N; Puren A; Hausler H
    BMC Infect Dis; 2020 Sep; 20(1):655. PubMed ID: 32894072
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Spending of HIV resources in Asia and Eastern Europe: systematic review reveals the need to shift funding allocations towards priority populations.
    Craig AP; Thein HH; Zhang L; Gray RT; Henderson K; Wilson D; Gorgens M; Wilson DP
    J Int AIDS Soc; 2014; 17(1):18822. PubMed ID: 24572053
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HIV and HCV among people who inject drugs in Central Asia.
    Walsh N; Maher L
    Drug Alcohol Depend; 2013 Nov; 132 Suppl 1():S37-40. PubMed ID: 23906997
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The cost-effectiveness of harm reduction.
    Wilson DP; Donald B; Shattock AJ; Wilson D; Fraser-Hurt N
    Int J Drug Policy; 2015 Feb; 26 Suppl 1():S5-11. PubMed ID: 25727260
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Annual HIV incidence fell by a third from 2000 to 2014.
    Gulland A
    BMJ; 2015 Dec; 351():h6492. PubMed ID: 26630902
    [No Abstract]   [Full Text] [Related]  

  • 37. The HIV epidemic associated with injecting drug use in Europe: geographic and time trends.
    Hamers FF; Batter V; Downs AM; Alix J; Cazein F; Brunet JB
    AIDS; 1997 Sep; 11(11):1365-74. PubMed ID: 9302447
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HIV/AIDS prevalence in the Southern Caucasus.
    Kvitsinadze L; Tvildiani D; Pkhakadze G
    Georgian Med News; 2010 Dec; (189):26-36. PubMed ID: 21252406
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Drug-related HIV epidemic in Pakistan: a review of current situation and response and the way forward beyond 2015.
    Bergenstrom A; Achakzai B; Furqan S; ul Haq M; Khan R; Saba M
    Harm Reduct J; 2015 Oct; 12():43. PubMed ID: 26471874
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.